These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1136002)

  • 1. [Tranexamic acid (Cyclocapron, Kabi). An antifibrinolytic].
    Storm O
    Ugeskr Laeger; 1975 May; 137(20):1120-1. PubMed ID: 1136002
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged treatment with tranexamic acid (Cyclocapron) during pregnancy].
    Storm O; Weber J
    Ugeskr Laeger; 1976 Jul; 138(29):1781-2. PubMed ID: 951789
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption of tranexamic acid as a prodrug in healthy volunteers.
    Svahn CM; Schannong M; Stenberg U; Widlund L
    Arzneimittelforschung; 1988 May; 38(5):735-8. PubMed ID: 3415720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of collagenosis treated with tranexamic acid (Cyclocapron)].
    Nymand G; Dyerberg J
    Ugeskr Laeger; 1975 Nov; 137(47):2786-7. PubMed ID: 1189103
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of ulcerative colitis by the direct administration of an antifibrinolytic agent as an enema.
    Kondo M; Hotta T; Takemura S; Yoshikawa T; Fukumoto K
    Hepatogastroenterology; 1981 Oct; 28(5):270-3. PubMed ID: 7047340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral disseminated lupus erythematosus treated with tranexamic acid (Cyclocapron)].
    Hansen PE; Hansen JH; Bramsen T
    Ugeskr Laeger; 1982 Aug; 144(31):2289-90. PubMed ID: 7147441
    [No Abstract]   [Full Text] [Related]  

  • 7. Tranexamic acid and gastric fibrinolysis in the rat.
    Stenberg B; Risberg B; Peterson HI
    Thromb Haemost; 1980 Feb; 42(5):1425-8. PubMed ID: 7368148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced cancer with Cyclocapron (tranexamic acid)].
    Rutqvist LE; Bolund C; Friberg S; Einhorn N; Wallgren A
    Lakartidningen; 1977 Aug; 74(32):2679-80. PubMed ID: 895275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rapid measurement of fibrinolytic activity in CSF by t-AMCA score method. Correlation with concentration of antifibrinolytic agent in CSF (author's transl)].
    Nishimatsu T; Shibasaki T; Sasaki H; Nukui H; Kawafuchi J; Okada K
    Rinsho Byori; 1980 Mar; 28(3):265-70. PubMed ID: 7373890
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of tranexamic acid.
    Astedt B
    Scand J Gastroenterol Suppl; 1987; 137():22-5. PubMed ID: 3321402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tranexamic acid on lung tissue fibrinolysis after trauma.
    Mattsson J; Peterson HI; Risberg B
    Bibl Anat; 1977; (16 Pt 2):416-8. PubMed ID: 603571
    [No Abstract]   [Full Text] [Related]  

  • 12. The preventative effect of the antifibrinolytic agents, epsilon-aminocaproic acid and tranexamic acid, on stress ulcer formation in rats.
    Kodama Y; Kumashiro R; Gain T; Matsumoto T
    Int Surg; 1983; 68(4):361-3. PubMed ID: 6668161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The action of fibrinolysis inhibitors of the omega-aminocarboxylic acid type on the proliferation of in vitro cultured endothelial cells].
    Pilgrim H
    Pharmazie; 1986 Jul; 41(7):519-20. PubMed ID: 3490674
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pharmacology of aminocaproic and tranexamic acids.
    Nilsson IM
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():41-7. PubMed ID: 7000846
    [No Abstract]   [Full Text] [Related]  

  • 15. On the effects of tranexamic acid and its isobenzedrine ester on plasminogen activation and streptokinase induced fibrinolysis.
    Baldacci M; Catalani R; Bartoli C; Del Corso A; Tozzi MG; Mura U
    Boll Soc Ital Biol Sper; 1989 Jun; 65(6):521-8. PubMed ID: 2611013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy.
    Woo KS; Tse LK; Woo JL; Vallance-Owen J
    Br J Clin Pract; 1989 Dec; 43(12):465-6. PubMed ID: 2611113
    [No Abstract]   [Full Text] [Related]  

  • 17. [Idiopathic thrombocytopenic purpura, associated with deep vein thrombosis induced by tranexamic acid].
    Endo Y; Iwamoto K; Itoh T; Miura A; Kuwayama A; Nishimura S
    Rinsho Ketsueki; 1988 Feb; 29(2):186-8. PubMed ID: 3385945
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of tranexamic acid on tumour blood flow.
    Sundbeck A; Alpsten M; Appelgren L; Karlsson L; Månsson LG; Peterson HI
    Anticancer Res; 1981; 1(3):141-8. PubMed ID: 7342852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tranexamic acid, a new antifibrinolytic agent].
    Kjellman H; Schannong M
    Nord Med; 1970 Feb; 83(6):166-8. PubMed ID: 4910677
    [No Abstract]   [Full Text] [Related]  

  • 20. [The prevention of dry socket].
    Combrink LW
    J Dent Assoc S Afr; 1986 Mar; 41(3):125-7. PubMed ID: 2981011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.